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Langerhans cells (LC) are bone marrow-derived, la +, CDl +, 
CD4 + , ATPase + dendritic antigen-presenting cel ls within 
the human epidermis. Since the CD4 molecule has been 
implicated as a receptor structure for HTL V -III/LA V (l1U-
man T-cell leukemia virus/lymphadenopathy-associated 
virus), we asked whether LC from HTL V-III/LA V -sero-
positive individuals display signs of HTL V-III/LA V infec-
tion . In skin biopsies from 7/40 HTLV-I1I /LAV-infected 
persons (1 asymptomatic carrier, 2 p·atients with acquired 
immunodefi ciency syndrome (AIDS)-related complex and 
4 patients with AIDS), LC were the only epidermal cells 
to react with a monoclonal antibody specific for the HTL V-
III core protein p17. A varying percentage of p17 + LC 
I t is genera ll y believed that the immunodeficiency in ARC/ AIDS (AIDS-related complex/acq uired immunodefi-ciency syndrome) patients is a direct consequence of a pro-no un ced affi nity of HTL V -III /LA V (human T-cell leukemia virus/lymphadenopathy-associated virus) for CD4 (T4) + 
helperlinducer T lymphocytes, which results in lethal damage of 
this critical immunocompetent cellular subset [1 J. Indeed, it is 
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Abbreviations: 
AIDS: acq uired immunodeficiency syndrome 
anti-p 17: monoclonal antibody against HTL V -III core protein p 17 
anti-p24: monoclonal antibody against HTLV-III core protein p24 
APC: antigen-presenting cell(s) 
ARC: AIDS-related com plex 
F1TC: fluorescein isothiocyanate 
HT LV-II1 : human T-celllcukemia virus 
KS: Kaposi's sarco ma 
LAV: lym phadenopathy-associated virus 
LC: Langerhans cell (s) 
moAB: monoclonal antibody(-ics) 
PBS: phosphate-buffered saline 
PE: phycoerythrin 
were morphologically altered with blunt dendrites and poorly 
demarcated cellular contours. In one of these biopsies, the 
presence of LC-associated viral particles characteristic of 
HTL V-III/LA V as well as cytopathic changes in approxi-
mately one-third of the LC population were demonstrated 
by electron microscopy. These results strongly suggest that 
LC may harbor HTLV-l\I /LA V. The infection ofLC with 
this retrovirus may have deleterious consequences for the 
immunologic functions of this cell sys tem and may thus 
contribute to both the acquisition of immunodefi ciency and 
the infectious and neoplastic complica tions of AIDS . J In-
vest D ermatol 88:233-237, 1987 
well established that H TL V -IIIILA V ca n frequently be detected 
in and isolated from culture fluids of lectin / lymphokine-driven 
peripheral blood mononuclear cells from ARC/ AIDS patients 
[2,3J. Furthermore, w hen peripheral mononuclear cells from healthy 
individuals are inocu lated w ith HTL V-IIIILA V, virus replication 
reportedly occurs predominantly in CD4 + lymphocytes (4J . This 
tropism is currently explained by the capacity of certa1l1 doma1l1s 
of the CD4 molecu le to serve as specific bindinglrecepto r struc-
tures fo r the retroviru s [5-8J. There now exists evidence that 
HTLV-lll /LAV can be encountered in follicular dendritic cells [9J 
and certain m ononuclear phagocytes (1 0, 11 J which also bear CD4 
antigens (12,13J. 
Langerhans cells (LC) are bone m arro w-derived dendritic cells 
w hich preferentially populate stratified squamous epithel!a. Within 
norm al hum an epidermis they are the o nly cells to exhibit ATPase 
activity, class II alloantigens, Fc-IgG and C3 receptor sites, CO l 
(T6) and, to a lesser extent, CD4 antigens [1 3-15J . In 1984, Belsito 
et al reported that ARC/AIDS patients have decreased numbers 
of Ia+/ATPase +/CD 1 + epiderm al LC [1 6, 17J. Such quantitative 
phenotypic alterations within the LC population of ARC/ AIDS 
patients m ay either occur as a direct consequence ofHTLV-lII/LAV 
infection of LC or their precursors o r, alternatively, represent a 
secondary phenomenon superimposed on an already existing state 
of HTLV-III /LA V-induced immunodysregulation. In this study, 
we used immuno fluorescence techniques employing monoclonal 
antibodies specific for HTL V -Ill core proteins as well as electron 
microscopic techniques to determine whether LC from HTL V-
Ill /LA V-seropositive individuals display alterations indicative of 
HTL V -IIIILA V infection. 
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PATIE NTS AND M ETHODS 
Patients O ur stud y popu lati on co nsisted of a to tal of 40 HTL V-
I1I1 LAV-seropos iti ve (A bbott E li sa and /o r specifi c bands by 
Western blot analys is) indi viduals suffer ing from either AIDS, 
ARC, or the asy mptomatic state of HTL V-III/LA V infection 
(Table I). Controls included HTLV-III /LA V-seronegative health y 
vo lun teers as well as HTL V-III/LA V -seronegative patients suf-
ferin g from a var iety of inflam matory and neop lastic skin dis-
o rders, including , ill particular, class ica l Kaposi 's sa rco ma (KS) 
and cutaneo us T -celil ymp hom3 (Table I). 
Tissue Salnpling and Processing In cisional o r 4-mm pun ch 
biopsy specimens were obtained fro m skin overl ayin g KS lesions 
in patients sufferin g from either AIDS-associated or classical KS 
and from lesio nal skin of control indi viduals with va ri ous patho-
logic skin co ndi tions. In all other subj ects, biopsy specimens of 
normal ski n were taken fro m rando ml y chosen body regions. 
Fresh biopsy specimens were snap-frozen in liquid nitrogen and 
stored at - 70°C un til use. Four-micron cryostat sections were 
mounted on glass slides, air-dr ied, aceto ne- fixed , and subj ected 
to immunohistologic processing. In so me patients, ep idermal sheets 
were prepared fro lll fres h biopsy specimens app lying an am-
monium-thiocya nate sepa ratio n techniqu e [1 8], fi xed , and sub-
jected to immuno his tologic processing in th e sa me mann e'r as 
were cryos tat sections. A biopsy specimen from one indiv id ual 
w ith anti-p17/anti-p24 (HTL V-III co re protein s)-reactive LC was 
processed for conventio nal electron mi croscopi c ana lysis. 
Monoclonal Antibodies T he fo ll owing monoclonal antibod ies 
(moAb) were used. (1) Anti-HTLV-III co re protein p17 \1 9]:lgG \. 
(2) Anti-HTL V-III co re protein p24 [20]:lgG \. The o ptim al wo rk-
in g d ilu tio ns for anti-p17 (5 JLg/ ml) and ant i-p24 (2 JLg/ml) were 
determ ined o n lym ph node cryostat sections from an ARC pa-
tient. In accorda nce w ith ea rlier reports 121] we fo und that an ti-
p17 and anti-p24 reacti vity was essentiall y confined to germin al 
centers and associated with dendritic cell s. (3) Fluorescein iso-
thi ocyanate (FlTC)-OKT6 (Ortho Inc. , fl..aritan, N ew Jer-
sey): lgG\; wo rking dilutio n = 1 :50. (4) Phycoerythrin (PE)-anti-
Leu-4 (Becton D ickinson, Sunn yva le, Ca liforn ia): lgG \; wo rkin g 
d ilu tion = 1 : 20. 
Immunohistologic Studies Fixed cryostat sectio ns (fixed epi-
derm al sheet prepa rations) were incubated for 30 min at room 
Table I. Anti-p17 React ivity of Ep idermal Lange rhans Cells 
in HTLV-IIlILA V-Infected and N o nin fected Individu als 
HTL V -III /LA V-seropositive persons 
Asymptomatic 
ARC 
AIDS 
KS 
O( 
Total 
HTL V-Ill/LA V-seronegative persons 
Healthy volunteers 
In flammatory skin disease 
Neoplastic skin disease other 
chan KS 
Class ical KS 
Total 
No. of persons! No. of Persons 
with 1'17 -'- LC Tested 
117 
2/ 11 
4"/16 
0/6 
7/40 
0/24 
0/40 
0/ 14 
1/6 
1/84 
Abbreviations: AIDS, acquired immu nodefi ciency syndrome; AnC, AIDS-re-
lated co mple x; KS. Kaposi's sarco ma; 0 1. opportunistic infcction(s). 
"In Dil l: of [hesc patients. :lIlti-p 17 rC:lCti v it y of LC was accompanied by anti-p24 
immunobbcling of th ese cells. In this specimen, the presence of Le-associated vira l 
part icles characteristic o f HTLV- III / LAV as well os cy topathic changes in approx-
im J.tel y o ne-third orrhe LC popu lation were demonstrated by cicctrolll11i crosco py . 
THE JOURNA L OF INVEST IGATIV E DERMATOLOGY 
temperature (16 h at 4°C) w ith the app ropriate ly di luted first-step 
mo noclonal reagent. To detect reactive cell s, FITC-labeled goat 
ant imo use IgG F(ab'h (Tago, In c., Burlingham , Ca lifo rnia) Or 
Texas Red AP rat Jntimouse IgG, F'2 Oackson Immuno resea rd"\ 
Laboratories, In c. , Avondale, Penn sy lvania) were used. For dou~ 
ble labeling purposes, the incubat ion chain was prolonged by first 
a 30-min in cubatio n w ith phosphate-buffered sa line (PBS)/5% 
norma l mouse serum followed by exposure of cryosta t sections 
(ep iderma l sheets) to FITC- o r PE-Iabeled moAb . Sectio ns (epi_ 
derm al sheets) were mOLlnted with PBS /glycerin e and examined 
under a Leitz-Ortholu x II flu orescence mi croscope with an ap_ 
prop riate FITC and PE filter setting. 
RES ULTS 
We ha ve identifi ed anti-p17-reactive epiderm al cells in skin biop_ 
sies from 7/40 I-IT L V-IlIlLA V-infected individua ls, onl y o ne of 
w hi ch additiona ll y showed the presence of p24 + ep idermal cells 
(Table I). T hese cell s were dendritic in shape, uni form ly expressed 
CO l anti gens, lacked CD3 (T3) anti gens and , thus, represented 
LC (Fig 1). In ce rtain sections, plr/CDl + LC ap peared to be 
se verely damaged w ith b lunt dendrites and a loss of mo rph o logic 
integrity. Serial sectioning revea led that the percentage of anti-
p17-reactive LC in a given biopsy specimen was quite va riable 
and ranged between 0-90% . T he reason for this large va ri ability 
ma y be due to the rather irregul ar and occasio nall y patchy dis-
tribution pattern of anti-p17-reactive LC as evidenced o n epi-
dermal sheet preparations. 
Heplacement of anti-p17/an ti-p24 by either isotype-matched 
mouse moAb or normal mo use serum cb nsis tenti y yielded neg-
ative res ults, as did th e use ofFITC-Jabeled antisera aga inst human 
Ig. T hi s latter findin g essenti all y excl ud es the possibility that anti-
p17/a nti-p24 stainin g has occurred as a conseq uence ofp17/anti-
p17 (p24/a n ti-p24) immune comp lex binding to LC Fc-lgG re-
ceptors. To determine w hether reactivity ofLC with moAb against 
HTLV-III /LAV core proteins is indi ca tive of the presence ofLC-
associated HTLV-Ill/LAV , we exa min ed by electron mi croscopy 
the epidermis of the biopsy specimen containing both p17 + and 
p24 + LC for the presence of virus particles. With the exception 
of sligh tly w idened intercellul ar spaces the overall st ru cture and 
organiza tion of the epidermis was well preserved. Infl ammatory 
cells were consistentl y absent. W hereas keratinocytes as well as 
melanocytes appeared entirely un altered, we found that app rox-
imate ly 30% of all LC-as identifi ed by their characterist ic Bir-
beck g ranu les [1 4]-displayed sig ns of moderate to severe damage, 
as evidenced by condensa tion of both cytoplasm and nuclear c1lro-
matin, sw elling o f cytoplas mic organelles, vacuole formation , and, 
occasiona ll y, fr:lI1k cytolysis (Fig 2). Since even the most severely 
inj ured cclIs regularly contained Birbeck granules, we conclude 
from these o bservations th at ultras tru cturally visible ep idermal 
cell injury in this given biopsy specimen is confin ed to the LC 
population . While intracytoplasmi c vira l particles were not de-
tected, mature viral particles were seen in intercellular spaces 
between normal-appearing LC and neighboring keratinocytes (Fig 
2). Whil e signs of ea rl y viral budding co uld no t be un eq uivoca lly 
dcmonstrated, intact LC occasio nall y exhibi ted surface protru-
sions indicative of late viral buds. Intercellular spaces between 
keratin ocy tes were devoid of these particles as were the surfaces 
o f and interce llular spaces surro undin g dama ged LC. Viral par-
ticl es were 90-11 0 nm ill diameter with a dense round-cy lindrical 
centra l core and a peripheral unit membrane. T hus, both the 
m orpho logy and size of these viral particles were consistent with 
that of HTL V-IlIlLA V. Although we cannot definitively prove 
that the cytopathi c changes seen in a subpopu lation of LC are 
due to injurious effects of these viral particles, we know of no 
other ski n condition w here, in the absence of any infl ammatory 
cells, moderate to seve re stru ctural changes are entirely confi ned ' 
to the LC population. 
Immuno histo logic exa min ation of skin bio psy specim ens from 
both hea lthy volunteers (11 = 24) and patients with a variety of 
either inflammatory (n = 40) o r neop las ti c (n = 20) sk in diseases 
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Figure 1. Immuno histo logic microg raphs of cryos t<lt scctio ns «(I ,b) and 
an ep idermal sheet preparation (c) of clinically normal skin from a 31-
yea r-o ld ARC paticnt; using indirect immunofluo rescence, Cl nti-HTLV-
[11 core protein p 17 moAb selecti vel y reacts with dendriti c ep idermal cel ls 
(a, arrolllhcads; c); th ese ce lls uniforml y ex press CD1 antigens as visua li zed 
by FlTC-OKT6 double-labeling (b, (/l'l'olllhcnds). The dOllcd lilies mark the 
dermal-epidermal junction (a,b). X 250. 
for the presence of anti-p 17 / anti-p24 im muno label in g co nsisten tl y 
yielded negati ve res ults w ith o ne notable excep ti on: a 40-year-
old male patient with KS of7 years' duration (Ta ble I). A bio psy 
specimen of les io nal sk in revea led the presence of anti-p17-
reactive, CD l I dendritic epiderm al cel ls. Since repea ted attem pts 
to detect circulating HTLV-IlIlLAV-specific antibodies were 
negative and since this pati ent neither belo ngs to an ARC/ AIDS 
hig h-risk g ro up no r d isplays signs of immunodefi ciency, a di-
agnosis of classica l KS rather than AIDS-associated KS is war-
ranted . Attempts to rescue th e virus £i,'o m skin bio psies and pe-
riph eral blood mo no nu clear cells fro m this patient by coculture 
with HTLV-Ill / LAV-permiss ive cell lines arc planned. It sho uld 
be no ted , however, that the presence of serum antibod ies to HTL V-
III is not an absolu te determining factor in ident ifying virus-
infected individuals sin ce, in infrequent instances, virus has been 
isolated from clini ca ll y normal, se ron egative don o rs [22]. 
LANGEIH-1ANS CELLS- A TAHGET FOH HTLV-111/ LAV 235 
DISCUSSION 
In v iew of recent studies showing that the CD4 anti gen-which 
serves as a critical bindinglreceptor structure for HTL V -Ill / LA V-
is present on epidermal LC [13-15], we asked w hether this cell 
system could be a site of HTLV-IlI / LA V infection. The results 
presen ted here strongly support this contention. We showed th at 
in 7 of 40 HTLV-IlIlLA V-seropositive individuals reactivity of 
LC with HTLV-IlI-speci£i c ant ibody occurred, and when one of 
these positive biopsy speci mens was examined electron mi cro-
scopica ll y we detected LC-associated vira l particles w hose size 
and morpho log y were consistent w ith that of HTL V-Ill / LA V. 
Additionall y, this biopsy specimen clearly showed that wh ile other 
epidermal ce lls were spa red , approximately 30% of LC displayed 
signs of moderate to severe damage. 
While in this particu lar patient , epidermal LC reacted with both 
anti-p1 7 and anti-p24 moAb, anti-p17 reactivity of LC in 6 ad-
ditional biopsy specimens from HTLV-IlIlLA V-seropositive in-
dividuals was not acco mpanied by anti-p24 staining. The rea-
son(s) for this discrepa ncy is (arc) presently unknown, and only 
limited experience exists rega rding the application of moA b against 
HTL V -III / LA V for immunohistologic purposes. It may simpl y 
be a q uantitative pheno menon, i.e., antibody-reactive epitopes of 
p17 antigens may be mo re abund ant and mo re accessible than 
antibody-reactive moieties of p24 antigens . 
The possibility that anti-p1 7 reacti vity of LC is due to cross-
reactivity of anti-p1 7 with non-HTL V -III-encoded proteins-
similar to the regularl y observed cross-reactivity of anti-HTLV-
I p1 9 with certa in ep ithelia [23]-ca nnot be definitively excluded . 
Since, however, 83 sk in biopsy specimens from both hea lth y 
donors and from patients with a wide variety of skin diseases 
were not reac tive w ith anti-p1 7, a cross-reactivity of this antibody 
w ith non-virus-encoded moieties appears extremely unlikely. While 
anti-p17 has been shown to be non-cross-reactive with HTLV-I 
and HTLV-1/ antigens (F. diMarzo Veronese, unpublished re-
sults) , the theoretica l possibility rema ins that anti-p17 cross-reacts 
with an as yet unknown human (rerro) virus capa ble of inducing 
the morphologic alteratio ns we o bserved in positively stained LC. 
Whether such a putative virus may even be linked to the occur-
ren ce of KS in the only anti-p1 7-reactive HTL V-III /LA V-sero-
nega tive individual is hi g hl y speculative and remains to be de-
termined in furthc:r studies. 
In spite of these caveats, we feel that , collectively, our resu lts 
(antibody reactivity, presence of retrov iral particles, damage of 
LC) favor the concept th at LC ca n be infected and, subseq uentl y, 
injured by HTL V-III / LA V. There are numcrous possible sites at 
which such an infection may occur, since LC o riginate from bone 
marrow precursors [24] and travel along 3n as yet unkno w n mi-
gration pathway to their epiderm al residence. 
The elucidation of the mode and site of infecti on ma y help to 
account for the va ri ability in th e number of ant ibody-reactive 
cells seen in different sections of the sa me biopsy. Since LC turn-
over in norma l epidermjs is a slow phenomenon, on ly an HTL V-
III/LA V infection oflong duration could lead to a hi gh proportion 
of antigen-positive cells at this site, sho uld the precurso rs be the 
initial target. If an infection of res idem LC occurs, a phenomeno n 
similar to that seen with T lymph ocytes may be operative: a 
possible "activation" o r alteration of these cells ma y promote 
their susceptibility to invasion by the virus. Since numerous fa c-
to rs may influence the turnover rate and the phenotype of these 
cells (e.g., physicochcm ical agents, drugs, so luble mediators) , 
multiple biopsy specimens from various sites taken at different 
times throughout the infectious process are needed to determine 
the actua l frequency of LC involvement in th e course of HTLV-
II IILA V infection . 
In genera l, detection ofHTLV-II I/LAV in lymphoid cells from 
infected individual s is a rarc event [25]. Virus detection ill llon-
T cel ls (mononu clear phagocytes , fo llicular dendritic cells) is at 
least cO.mparabl e in freq uency to that enco untered in T cell s [21] . 
It may well be that T cell s are m ore prone to HTLV-III / LAV-
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Figure 2. E lectron micrographs of clini-
ca ll y no rmal epidermis o verla ying a KS le-
sion of a 56-year-old AIDS patient . Whereas 
the majo rity of LC, as identified by the pres-
ence of Birbeck g ranules (arrows) , appear 
mo rpho logica ll y intact (a), approximate ly 
30% show severe cy toplas mic degeneration 
and cy tolysis (c). Typical 90-110 nm retro-
virus-like particles w ith a dense core were 
found in about 5% of the ultrathin' sections 
exa mined and wete confined to the inter-
cellular space between normal-appearing LC 
and adjacent keratinocytes [reefal/gll /aled area 
in (a) ]. Fig ure b shows a higher magnifica-
tion of this area revea lin g viral particles be-
tween sm all villous processes of a LC (top) 
and a keratinocyte (bottom). One of these 
vi llo us processes shows surface pro trusio ns 
indi ca ti ve o f a late vira l bud (arrowhead}. 
induced cytopathy than CD4 + non-T cells [26]. Should this be 
.true , cells of the mononuclear phagocyte system as well as LC 
might serve as a reservoir for this retrovirus and thus criti ca lly 
influence the course of the disease. 
Further implications of our results ca n be deduced from what 
is kn own about th e biologic functions of epidermal LC. It is firmly 
established that, similar to m onocyte/macrophages, these cells 
are antigen-presenting cells (APC) and are respon sible for elici-
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tation ofT- cell responses toward antigens introdu ced via th e skin 
or, perhaps, even neoantigens originating in the skin [1 4). The 
consequences of HTLV-IIl/LA V infection of APC may be two-
fold. On the one hand, it may impair the capacity of these cells 
to present antigen to T cells in an immunologica lly relevant fash-
ion. Should, o n th e otber hand, HTLV-III /LAV-infectcd APC 
maintain their capacity to interact w ith lymphocytes, a trans-
mission of thi s retroviru s into the T-cell compartment might 
VOL. 88. N O.2 FE 13RUAI1Y 1987 
occur. Either event o r bo th events wo uld result in a state o f 
immunodefi ciency co ntributin g to the infectio us and neoplas ti c 
compli catio ns of AIDS. 
We wish to tlwlIl.! Drs. E. M. Shellach ali(I I. Creell , alld M rs. L. A. Stills l 
jar he/pjlll sl/.l!.~estiv II s ali(I disCllssieJII s, Mrs. A. l-iaITer jor expert tedllli((l / ({S-
sistallce, ali(I AIls. S. S tantes ./01' w rejidl ), t )'pill.~ this //lallI/script . 
Note added in proof: Followin g submission of this m anu-
script, ultrastructural exa mination of an additional biopsy spec-
Imen fro l11 the patient with p1 7 + / p24 + LC now revea led un-
equivoca l sig ns o f HTL V -III / LA V - like virus budding fro m LC. 
(P. Schenk et aI, m anuscript in preparatio n). 
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